A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the pharmacokinetics, tolerability, and safety of
exenatide once weekly suspension in both healthy subjects and in subjects with type 2
diabetes. The study will also evaluate efficacy in the type 2 diabetes patients. Development
of this exenatide once weekly presentation would eliminate the need to reconstitute the
product prior to use.